Your browser doesn't support javascript.
loading
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma.
Nakagawa, Makoto; Yamaguchi, Masayuki; Endo, Makoto; Machida, Yukino; Hattori, Ayuna; Tanzawa, Fumie; Tsutsumi, Shinji; Kitabayashi, Issay; Kawai, Akira; Nakatani, Fumihiko.
Afiliación
  • Nakagawa M; Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
  • Yamaguchi M; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Endo M; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan.
  • Machida Y; Division of Functional Imaging, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba, Japan.
  • Hattori A; Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Tanzawa F; Department of Veterinary Pathology, Nippon Veterinary and Life Science University, Tokyo, Japan.
  • Tsutsumi S; Division of Hematological Malignancy, National Cancer Center Research Institute, Tokyo, Japan.
  • Kitabayashi I; Department of Biosystems Science, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Kawai A; Oncology Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
  • Nakatani F; Oncology Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
J Bone Oncol ; 34: 100430, 2022 Jun.
Article en En | MEDLINE | ID: mdl-35493690

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Bone Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Bone Oncol Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Países Bajos